Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Damora Therapeutics, Inc. market cap for the quarter ending 2026-08-07 was $1.85B, a 43396.25% increase year-over-year.
Damora Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $1.6B, a 35422.94% increase year-over-year.
Damora Therapeutics, Inc. market cap for the quarter ending 2026-05-11 was $1.5B, a 37184.35% increase year-over-year.
Damora Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $1.56B, a 38015.08% increase year-over-year.
Damora Therapeutics, Inc. market cap for fiscal 2026 was $1.85B.
Damora Therapeutics, Inc. market cap for fiscal 2025 was $36.75M, a 500.17% increase from fiscal 2024.
Damora Therapeutics, Inc. market cap for fiscal 2024 was $6.12M, a 68.63% decline from fiscal 2023.
Damora Therapeutics, Inc. market cap for fiscal 2023 was $19.52M, a 97.35% decline from fiscal 2022.